Coffee, Green Tea, and Type 2 Diabetes Mortality Rates
Previous studies in the general population suggest that both green tea and coffee can contribute to health benefits, preventing chronic diseases, and even reducing mortality risks. However, limited evidence is currently available regarding the consumption of these beverages on patients with type 2 diabetes mellitus. There is significant potential for reduced all-cause mortality associated with […]
Follow-Up of EDICT Study Demonstrates Long-Term Efficacy of Initial Combination Therapy in T2DM Management
Type 2 diabetes mellitus (T2DM) affects approximately 28 million people in the United States and is characterized by hyperglycemia due to insulin resistance and impaired β-cell function. Its prevalence has almost doubled in the last two decades and diabetes costs the economy $245 billion annually; with most of these costs attributed to T2DM. The rapid […]
Inflammation and risk of T2DM: Insights from the CANTOS trial
Data from several studies have suggested that persistent low-grade inflammation has an important role in the pathophysiology of many cardiometabolic conditions. Inflammatory markers, such as interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hs-CRP) have been associated with increased risk of cardiovascular adverse events, as well as insulin resistance and hyperglycemia. Canakinumab is a human monoclonal antibody […]
